Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 3 Ovarian Neoplasms 2 Disease 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pain 1 Neoplasms 1 Lung Neoplasms 1 Liver Cirrhosis 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Capecitabine 41 Oxaliplatin 39 Fluorouracil 29 Leucovorin 23 Radiotherapy 21 Cetuximab 14 Bevacizumab 14 Irinotecan 13 Nivolumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Surgical Procedures, Operative 8 Folfox protocol 8 Drug Therapy 8 pembrolizumab 7 Radiotherapy, Intensity-Modulated 7 Chemoradiotherapy 7 Biopsy 7 trifluridine tipiracil drug combination 6 Radiation 6 tislelizumab 5 sintilimab 5 regorafenib 5 dehydroftorafur 5 X-Rays 5 Surveys and Questionnaires 5 Sigmoidoscopy 5 Endoscopy 5 Consolidation Chemotherapy 5 spartalizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Preoperative Exercise × 1 year × Clear all

NCT03876561 2026-04-20

CONTICARE

Nantes University Hospital

Phase NA Terminated

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡